Offer Price Between HK$8.60 and HK$9.78 per Share To Raise Proceeds Up to HK$1,947 and 2,214 Million A leading player…
Browsing: BioTech
2021-6-23 / Gelonghui – China Biotech’s cell therapy was approved by the NMPA to enter Phase I clinical trials as…
Avance Clinical, the leading Australian CRO for international biotechs and Frost & Sullivan Asia-Pacific CRO Market Leadership Award recipient, announced…
Avantor, a leading global provider of mission-critical products and services to customers in the life sciences and advanced technologies and…
Amid rising concerns over the threat and economic impact of COVID-19, Holista Colltech Ltd (Holista) has been granted permission for…
China’s leading integrated online healthcare platform Dingdang Health announced today that it has raised US$220 million in its latest financing…
The leading Australian CRO for biotechs and Frost & Sullivan Asia-Pacific CRO Market Leadership Award recipient Avance Clinical announced the…
Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences and…
Contribution of Sales of New Products to Revenue Rises to 47.4% Driving Revenue Up by 16.4% Sino Biopharmaceutical Limited (Sino…
Signifying Government Recognition in The Company’s Quality Manufacturing System Zhaoke Ophthalmology Limited (stock code: 6622), an ophthalmic pharmaceutical company dedicated…
Agilex Biolabs, Australia’s largest and most technologically advanced specialist bioanalytical laboratory for clinical trials is partnering with Endpoints News to…
Apollomics Inc., an innovative biopharmaceutical company committed to the discovery and development of mono- and combination- oncology therapies, today announced…
USFDA NDI notification of Antromax “Antrodia cinnamomea mycelia” The history of Antrodia cinnamomea consumption by indigenous tribes in Taiwan dates back…
The leading Australian CRO for biotechs and Frost & Sullivan Asia-Pacific CRO Market Leadership Award winner, Avance Clinical, has expanded…
Agilex Biolabs, Australia’s largest and most technologically advanced specialist bioanalytical laboratory for clinical trials, and B2S Life Sciences, a biotherapeutic…
Scivita Medical Technology Co., Ltd. (“civita Medical) today announced that it has raised nearly RMB0.4 Billion in Series A funding…
Hua Medicine (Stock Code: 2552.HK), today announced that the New Drug Application (NDA) for dorzagliatin for the treatment of Type…
The leading Australian CRO for biotechs and Frost & Sullivan Asia-Pacific CRO Market Leadership Award winner Avance Clinical has been…
Cielo, the world’s leading Recruitment Process Outsourcing (RPO) provider, has renewed its partnership with Sanofi, a global biopharmaceutical company, to…
Agilex Biolabs, Australia’s largest and most technologically advanced specialist bioanalytical laboratory for clinical trials, today announced the acquisition of leading…